Skip to content

Don't Wait to Diagnose AMD

Are your patients going undiagnosed?

Age-related macular degeneration (AMD) is the leading cause of adult blindness in developed countries. In fact, AMD is three times more prevalent than glaucoma. And the problem is only expected to grow as the population ages.

A 2017 study published in JAMA Ophthalmology estimates there are currently 14 million patients with AMD in the U.S. But even with regular exams using current imaging tools, an additional 25% are undiagnosed.1 What does that 25% mean to your practice?


How Many AMD Patients Are in Your Practice?

Let’s do the math. Enter your information below to estimate how many of your patients can benefit from earlier AMD detection.


The current standard is for us to wait around until we see macular degeneration progressing in someone’s eye. We now know we can identify it earlier, up to 3 years earlier before it ever shows up in their eye. I truly believe dark adaptation testing should be the standard of care.

RyanPowell Ryan Powell, OD View all testimonials
Man Squinting AMD AdaptDx

Stages of AMD

As a progressive disease, AMD reveals itself in stages. Detecting AMD at the subclinical level offers patients the best chance to prevent blindness.

Night Driving AMD AdaptDx

Symptoms & Risk Factors

Understanding the symptoms and risk factors will help identify AMD earlier.

Linking Dark Adaptation and AMD

Research shows that dark adaptation is the earliest warning sign of AMD.


AMD Testing Options

Is your practice making the best use of the available AMD testing methods?

Retinal Light Protection AMD AdaptDx

AMD Treatments

Starting treatment of AMD early helps delay or prevent blindness.

How AdaptDx Pro Helps Detect AMD

AMD Detection

The AdaptDx Pro™ testing tool from MacuLogix® offers you the chance to diagnose AMD before vision loss occurs.

AMD Research

Compelling research proves MacuLogix dark adaptometers reveal the earliest signs of AMD.